QSS
UTHR icon

Quantitative Systematic Strategies’s United Therapeutics UTHR Stock Holding History

Quantitative Systematic Strategies’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-7,286
Closed -$642K – 533
2019
Q4 		$642K Buy
7,286
+1,609
+28% +$142K 0.09% 289
2019
Q3 		$453K Buy
+5,677
New +$457K 0.1% 254
2016
Q2 		– Sell
-2,089
Closed -$230K – 529
2016
Q1 		$230K Buy
+2,089
New +$264K 0.09% 235
2015
Q3 		– Sell
-1,987
Closed -$340K – 536
2015
Q2 		$340K Buy
+1,987
New +$357K 0.08% 400
2014
Q4 		– Sell
-3,276
Closed -$435K – 426
2014
Q3 		$435K Sell
3,276
-1,274
-28% -$131K 0.25% 171
2014
Q2 		$407K Sell
4,550
-6,742
-60% -$648K 0.29% 138
2014
Q1 		$1.03M Buy
+11,292
New +$1.15M 0.85% 7

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Quantitative Systematic Strategies's UTHR Position: Q1 2020 in Review

Quantitative Systematic Strategies sold out of United Therapeutics (UTHR) in Q1 2020, closing a stake of 7,286 shares — an estimated $642K sold.

Quantitative Systematic Strategies first reported a position in UTHR in Q1 2014 and held it in 7 quarters. The position peaked at $1.03M in Q1 2014. 303 funds tracked by Wall St. Rank hold UTHR as of Q1 2020.

  • Quantitative Systematic Strategies reported no remaining United Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 7,286 United Therapeutics shares in Q1 2020, an estimated $642K.
  • Quantitative Systematic Strategies first reported a position in United Therapeutics in Q1 2014 and held it in 7 quarters.
  • Quantitative Systematic Strategies's United Therapeutics position peaked at $1.03M in Q1 2014.
  • 303 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2020, filed 6 May 2020.